Sylvie Bertholet Selected Research

Sylvie Bertholet Research Topics

Disease

11	Infections 01/2016 - 04/2003
8	Human Influenza (Influenza) 01/2016 - 10/2010
6	Tuberculosis (Tuberculoses) 09/2013 - 12/2008
6	Leishmaniasis 11/2012 - 09/2003
3	Visceral Leishmaniasis (Kala Azar) 05/2009 - 04/2003
2	Peritonitis 01/2016 - 01/2015
2	Cutaneous Leishmaniasis 05/2009 - 09/2003
2	Inflammation (Inflammations) 11/2007 - 09/2003
1	Confusion (Bewilderment) 06/2022
1	Diphtheria 01/2018
1	Tetanus 01/2018
1	Whooping Cough (Pertussis) 01/2018
1	Virus Diseases (Viral Diseases) 01/2016
1	Abscess 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Superinfection 01/2016
1	Neutropenia 08/2015
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 08/2014
1	Communicable Diseases (Infectious Diseases) 04/2013
1	Bites and Stings (Sting) 11/2012
1	Vivax Malaria 05/2012
1	Malaria 09/2011
1	Pulmonary Tuberculosis 08/2011
1	Otitis 11/2007
1	Parasitic Diseases (Parasitic Disease) 09/2006
1	Brucellosis (Malta Fever) 02/2004
1	Reinfection 09/2003

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 01/2018 - 09/2003
12	AntigensIBA 01/2018 - 09/2003
7	Proteins (Proteins, Gene)FDA Link 06/2022 - 12/2008
5	Subunit VaccinesIBA 01/2016 - 12/2008
4	AntibodiesIBA 01/2016 - 09/2011
4	CytokinesIBA 08/2015 - 04/2003
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2016 - 01/2015
3	Neuraminidase (Sialidase)IBA 01/2015 - 08/2013
2	Hemagglutinins (Hemagglutinin)IBA 01/2018 - 08/2013
2	Neutralizing AntibodiesIBA 01/2016 - 01/2015
2	MF59 oil emulsionIBA 01/2016 - 01/2015
2	aluminum sulfate (alum)IBA 01/2016 - 01/2015
2	EmulsionsIBA 01/2015 - 05/2009
2	Rifampin (Rifampicin)FDA LinkGeneric 04/2013 - 11/2007
2	PolyproteinsIBA 11/2012 - 10/2010
2	Interferon-gamma (Interferon, gamma)IBA 11/2007 - 09/2003
1	Indicators and Reagents (Reagents)IBA 06/2022
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Pertussis ToxinIBA 01/2018
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2018
1	pertactin FDA Link 01/2018
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 01/2018
1	mRNA VaccinesIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Lipid NanoparticlesIBA 01/2016
1	Combined VaccinesIBA 01/2015
1	LectinsIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2015
1	EnzymesIBA 01/2015
1	Pattern Recognition ReceptorsIBA 08/2014
1	Immunoglobulin A (IgA)IBA 04/2014
1	Synthetic Vaccines (Recombinant Vaccines)IBA 08/2013
1	Tuberculosis VaccinesIBA 04/2013
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2013
1	Leishmaniasis VaccinesIBA 11/2012
1	Malaria VaccinesIBA 09/2011
1	Mycobacterium tuberculosis antigensIBA 08/2011
1	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 10/2010
1	Interleukin-2 (IL2)IBA 10/2010
1	monophosphoryl lipid AIBA 05/2009
1	SterolsIBA 10/2007
1	Histocompatibility Antigens Class IIBA 09/2006
1	EpitopesIBA 10/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2004
1	IgE Receptors (Fc epsilon RI)IBA 02/2004
1	CPG-oligonucleotideIBA 09/2003
1	OligodeoxyribonucleotidesIBA 09/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2013 - 08/2011
1	Duration of Therapy 04/2013
1	Therapeutics 08/2011
1	Injections 10/2010
1	Ligation 02/2004